# Human Papillomavirus (HPV) Self-sampling as a Test of Cure After Treatment of Cervical Intra-epithelial Neoplasia

> **NCT02780960** · NA · COMPLETED · sponsor: **University Hospital, Geneva** · enrollment: 127 (actual)

## Conditions studied

- Cervical Intra-epithelial Neoplasia Grade 1 or Worse

## Interventions

- **DEVICE:** HPV self-testing

## Key facts

- **NCT ID:** NCT02780960
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2020-09
- **Final completion:** 2020-10
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2021-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02780960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02780960, "Human Papillomavirus (HPV) Self-sampling as a Test of Cure After Treatment of Cervical Intra-epithelial Neoplasia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02780960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*